Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effectsL Pricop, H Rabinowich, P A Morel, et al.
Clinical Immunology and Immunopathology|June 1, 1991
Expression of Fc mu receptors on human natural killer cellsL Pricop, C Galatiuc, M Manciulea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokinesL Pricop, P Redecha, J L Teillaud, et al.
International Immunology|December 1, 1994
Antibody response elicited by T-dependent and T-independent antigens in gene targeted kappa-deficient miceL Pricop, T Brumeanu, E Elahi, et al.
Blood|January 15, 1998
A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptorC F Norris, L Pricop, S S Millard, et al.
The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.
Arthritis Research & Therapy|May 4, 2019
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataA Deodhar, P J Mease, I B McInnes, et al.
Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.
Pageof 2